are glp-1 biologics pharmaindustry #glp1 #patentcliff #obesitytreatment #diabetescare #indianpharma #biologics A new study found that

Prescribers longstanding preferences for established injectables, along with the commonly held view that injections are more effective, can also shape adoption

Lixisenatide is also a synthetic version of exendin-4 that has modifications consisting of the deletion of one proline residue and the addition of six lysine residues at the C-terminal end, which increases its half-life and its binding affinity to GLP-1R

Nutr Neurosci 25:10781099

10.1111/imr.13235 40 TianP.XuZ.GuoJ.ZhaoJ.ChenW.HuangW.et al (2024)

Important: CJC-1295 and Ipamorelin are research/compounded peptides and are not FDA-approved as a weight-loss or anti-aging drug